Page last updated: 2024-10-21

5-carboxamidotryptamine and Arteriosclerosis

5-carboxamidotryptamine has been researched along with Arteriosclerosis in 2 studies

5-carboxamidotryptamine: agonist of 5-HT receptor; structure given in first source

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, T1
Chiba, S1
Ishida, T1
Kawashima, S1
Sakoda, T1
Shimokawa, Y1
Miwa, Y1
Inoue, N1
Ueyama, T1
Shiomi, M1
Akita, H1
Yokoyama, M1

Other Studies

2 other studies available for 5-carboxamidotryptamine and Arteriosclerosis

ArticleYear
Augmented responses to 5-HT2-receptor-mediated vasoconstrictions in atherosclerotic rabbit common carotid arteries.
    Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Arteriosclerosis; Carotid Arteries; Disease Models,

1995
Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries.
    Circulation, 2001, Mar-06, Volume: 103, Issue:9

    Topics: Animals; Arteriosclerosis; Calcium; Coronary Vessels; Dose-Response Relationship, Drug; Female; In V

2001